David Shaw’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

David Shaw’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,266	Closed	-$59.7K	–	4377
2023 Q1	$59.7K	Sell	17,266 -80,254	-82%	-$389K	﹤0.01%	4022
2022 Q4	$408K	Buy	97,520 +6,325	+7%	+$23.9K	﹤0.01%	3964
2022 Q3	$366K	Buy	91,195 +22,095	+32%	+$168K	﹤0.01%	4214
2022 Q2	$781K	Sell	69,100 -13,099	-16%	-$157K	﹤0.01%	3793
2022 Q1	$1.33M	Buy	82,199 +16,914	+26%	+$433K	﹤0.01%	3669
2021 Q4	$3.09M	Sell	65,285 -155,996	-70%	-$9.36M	﹤0.01%	2921
2021 Q3	$16M	Buy	221,281 +62,823	+40%	+$4.54M	0.01%	1170
2021 Q2	$13.3M	Buy	158,458 +120,642	+319%	+$7.96M	0.01%	1272
2021 Q1	$1.83M	Buy	+37,816	New	+$2.05M	﹤0.01%	2662

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

David Shaw's NBP Position: Q2 2023 in Review

David Shaw sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2023, closing a stake of 17,266 shares — an estimated $59.7K sold.

David Shaw first reported a position in NBP in Q1 2021 and held it in 9 quarters. The position peaked at $16M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q2 2023.

David Shaw reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2023 after selling out during the quarter.
David Shaw sold 17,266 NovaBridge Biosciences American Depositary Shares shares in Q2 2023, an estimated $59.7K.
David Shaw first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 9 quarters.
David Shaw's NovaBridge Biosciences American Depositary Shares position peaked at $16M in Q3 2021.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.